Cardinal Health opens the week with a clear analyst picture, shares near recent highs
23.06.2026 - 13:17:22 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 13:14.
Cardinal Health (US14149Y1082) opens the new week with its shares trading on the NYSE close to recent highs, supported by a broadly positive analyst consensus. According to data compiled by MarketScreener, most covering analysts rate the stock Buy or Outperform with an average 12-month target above the current price.MarketScreener analyst overview for Cardinal Health
What analysts are saying today
Cardinal Health is covered by large houses including Goldman Sachs, JPMorgan and UBS, which collectively provide a structured view on earnings prospects and capital returns.TipRanks consensus on CAH Recent consensus figures point to a target price area around 245 dollars per share, compared with a cash market level slightly above 220 dollars as of the last trading session.Pandaforecast data on Cardinal Health shares
The analyst distribution is tilted towards positive ratings, with a minority of Hold recommendations and very few Sells on record.MarketScreener analyst overview for Cardinal Health Cardinal Health’s positioning as one of the three large US pharmaceutical distributors, alongside McKesson and AmerisourceBergen, underpins the stable long-term view.
Consensus numbers and valuation
On current forecasts, Wall Street expects Cardinal Health to generate steady earnings growth over the next two fiscal years, helped by cost controls and contract renewals with major pharmacy chains.TipRanks consensus on CAH The average price target cited by several sources sits around 245 dollars, implying moderate upside from the latest closing level near 223 dollars.Pandaforecast data on Cardinal Health shares
Valuation metrics remain in a range considered fair for a mature distributor. Cardinal Health trades on earnings multiples that reflect its defensive role in the US healthcare system, while the shares have delivered marked gains over the past 12 months.Pandaforecast data on Cardinal Health shares In the broader S&P 500 healthcare sector, McKesson and AmerisourceBergen are the closest peers for investors comparing distribution-focused names.
More news and data on the Cardinal Health shares
All recent headlines, key figures and historical price data on Cardinal Health are bundled on the dedicated topic page and in the company’s investor relations section.
The business behind the stock
Cardinal Health generates most of its revenue from pharmaceutical distribution in the United States, delivering branded and generic medicines to hospitals, pharmacies and other healthcare providers.Cardinal Health company overview A second significant segment focuses on medical products, including surgical supplies and lab goods, which complement the core distribution platform.
Where the shares trade now
The Cardinal Health shares (US14149Y1082) trade on the NYSE at around 222.74 dollars as of 2026-06-22, according to recent quote data.Pandaforecast data on Cardinal Health shares This price level reflects the latest regular-session close before today’s US trading begins.
Cardinal Health at a glance
- Company: Cardinal Health Inc.
- ISIN: US14149Y1082
- WKN: 879194
- Ticker: CAH
- Trading venue: NYSE
- Price (as of 2026-06-22, 21:00): 222.74 USD
- Market cap: around 55 billion USD (as of 2026-06-22)
- Sector / industry: Healthcare distribution / medical supplies
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a buy or sell recommendation, or a solicitation to trade Cardinal Health shares or any other securities. All data are based on sources cited in the text and may change without notice.
